That’s a poor excuse being blind to something we
Post# of 153886
(Total Views: 503)
Posted On: 11/07/2023 1:15:34 PM
Re: generactor #138833
That’s a poor excuse being blind to something well millions of people were dying.
Unless remdesivir was some miracle drug, which we know it wasn’t, why would he completely dismiss a potential better drug to treat covid.
I think he has to explain himself or anyone else that was involved with Leronlimab. People died, mistakes were made. As long as you acted in good faith, fine things happen, the system isn’t perfect.
However, anyone that worked for the FDA owes the public a response. I’m a public employee and I never have an issue being investigated because I do what’s right, if anything I enjoy transparency. Same goes for these employees they should embrace it. Could you imagine if these people had to wear body cameras. I bet you some of them are deleting emails as we speak! Ok maybe not. You get my point.
However, the fact some of them lurked on here and still didn’t understand how Leronlimab worked is disturbing. At the very least Leronlimab deserves a fair shake.
Once again you stop giving a drug after two weeks. That is absolutely the dumbest thing anyone could ever do during a trial especially when the CMO, at the time, highly recommended 4 weeks of treatment along with other individuals. You can’t make an argument against that? Can someone explain why this would make sense?
Maybe the FDA can explain this. Regardless we deserve answers, hopefully we get them. If not we should demand them at some point, but it looks like there is questions being asked at the highest levels. It’s a start.
Sorry just frustrated after reading Dr Jays email. Maybe a little more context will help me see things differently.
Unless remdesivir was some miracle drug, which we know it wasn’t, why would he completely dismiss a potential better drug to treat covid.
I think he has to explain himself or anyone else that was involved with Leronlimab. People died, mistakes were made. As long as you acted in good faith, fine things happen, the system isn’t perfect.
However, anyone that worked for the FDA owes the public a response. I’m a public employee and I never have an issue being investigated because I do what’s right, if anything I enjoy transparency. Same goes for these employees they should embrace it. Could you imagine if these people had to wear body cameras. I bet you some of them are deleting emails as we speak! Ok maybe not. You get my point.
However, the fact some of them lurked on here and still didn’t understand how Leronlimab worked is disturbing. At the very least Leronlimab deserves a fair shake.
Once again you stop giving a drug after two weeks. That is absolutely the dumbest thing anyone could ever do during a trial especially when the CMO, at the time, highly recommended 4 weeks of treatment along with other individuals. You can’t make an argument against that? Can someone explain why this would make sense?
Maybe the FDA can explain this. Regardless we deserve answers, hopefully we get them. If not we should demand them at some point, but it looks like there is questions being asked at the highest levels. It’s a start.
Sorry just frustrated after reading Dr Jays email. Maybe a little more context will help me see things differently.
(4)
(0)